KKR touted the close of its second dedicated healthcare growth equity investment fund that will target opportunities primarily in North America and Europe.
The KKR Health Care Strategic Growth Fund II raised $4 billion and follows the firm’s first vehicle that closed in November 2017 with $1.45 billion in capital commitments. The strategy is to invest in health care companies with proven products and services that are seeking a partner to commercialize and scale.
Keeping with a diversified portfolio approach, the latest KKR fund will invest in biopharmaceutical, medical device, healthcare services, life . . .
Continue Reading
Unlock this article instantly, along with the rest of our premium content and benefits including daily/weekly/monthly newsletters.
Monthly
$30
A pay-as-you-go plan to get you started
→ Instantly unlock all new and archived articles
→ Daily, weekly and monthly e-mail newsletters
→ Access to the weekly AW Deal Watch by AW Research
Annual
$300
Required for access to AW Research
Get more for less - 20% discount over monthly
→ Everything in Monthly PLUS:
→ Access to articles and data from AW Research
→ AW Annual Investor Compendium – our comprehensive guide to investor activity, with a ranking of the most active investors for the year and profiles of the top global allocators
